A Single Arm, Prospective, Open Label, Multi Center, Phase Ib Study to Evaluate the Safety, Tolerability and Initial Efficacy of a Single Intra-tumoral Injection of IntraGel's Polymer-based Cisplatin-loaded Gel (TumoCure) in Subjects With Progressive or Radio-resistant Primary Head and Neck Tumor
Clinical trial NCT05200650 · RECRUITING
Trial details
- NCT number
- NCT05200650
- Sponsor
- IntraGel Therapeutics
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-15
- Primary completion
- 2025-05-15
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.